{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:42Z","timestamp":1793379942197,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-026-02263-0","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:02:51Z","timestamp":1770026571000},"page":"718-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["mRNA vaccination overcomes haemozoin-mediated impairment of whole-parasite malaria vaccines in mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Mariah","family":"Hassert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Drewry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lecia L.","family":"Pewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1940-2619","authenticated-orcid":false,"given":"Lisa S.","family":"Hancox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahaana","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison R.","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-6633","authenticated-orcid":false,"given":"Aliasger K.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-2802","authenticated-orcid":false,"given":"John T.","family":"Harty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2263_CR1","unstructured":"World Health Organization World Malaria Report 2023 (World Health Organization, 2024)."},{"key":"2263_CR2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1086\/597121","volume":"199","author":"ED Putrianti","year":"2009","unstructured":"Putrianti, E. D., Silvie, O., Kordes, M., Borrmann, S. & Matuschewski, K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J. Infect. Dis. 199, 899\u2013903 (2009).","journal-title":"J. Infect. Dis."},{"key":"2263_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.977472","volume":"13","author":"H Nunes-Caba\u00e7o","year":"2022","unstructured":"Nunes-Caba\u00e7o, H., Moita, D. & Prud\u00eancio, M. Five decades of clinical assessment of whole-sporozoite malaria vaccines. Front. Immunol. 13, 977472 (2022).","journal-title":"Front. Immunol."},{"key":"2263_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/216160a0","volume":"216","author":"R Nussenzweig","year":"1967","unstructured":"Nussenzweig, R., Vanderberg, J., Most, H. & Orton, C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216, 160\u2013162 (1967).","journal-title":"Nature"},{"key":"2263_CR5","doi-asserted-by":"publisher","first-page":"e31247","DOI":"10.1371\/journal.pone.0031247","volume":"7","author":"WR Weiss","year":"2012","unstructured":"Weiss, W. R. & Jiang, C. G. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS ONE 7, e31247 (2012).","journal-title":"PLoS ONE"},{"key":"2263_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614\u2013623 (2016).","journal-title":"Nat. Med."},{"key":"2263_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475\u2013480 (2011).","journal-title":"Science"},{"key":"2263_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","volume":"266","author":"DF Clyde","year":"1973","unstructured":"Clyde, D. F., Most, H., McCarthy, V. C. & Vanderberg, J. P. Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 266, 169\u2013177 (1973).","journal-title":"Am. J. Med. Sci."},{"key":"2263_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","volume":"45","author":"D Fernandez-Ruiz","year":"2016","unstructured":"Fernandez-Ruiz, D. et al. Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889\u2013902 (2016).","journal-title":"Immunity"},{"key":"2263_CR10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.chom.2020.04.010","volume":"27","author":"AM Valencia-Hernandez","year":"2020","unstructured":"Valencia-Hernandez, A. M. et al. A natural peptide antigen within the Plasmodium ribosomal protein RPL6 confers liver TRM cell-mediated immunity against malaria in mice. Cell Host Microbe 27, 950\u2013962.e957 (2020).","journal-title":"Cell Host Microbe"},{"key":"2263_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109956","volume":"37","author":"MN Lefebvre","year":"2021","unstructured":"Lefebvre, M. N. et al. Expeditious recruitment of circulating memory CD8 T cells to the liver facilitates control of malaria. Cell Rep. 37, 109956 (2021).","journal-title":"Cell Rep."},{"key":"2263_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1073\/pnas.85.2.573","volume":"85","author":"WR Weiss","year":"1988","unstructured":"Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci. USA 85, 573\u2013576 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2263_CR13","doi-asserted-by":"publisher","first-page":"e1012731","DOI":"10.1371\/journal.ppat.1012731","volume":"21","author":"MN de Menezes","year":"2025","unstructured":"de Menezes, M. N. et al. Long lived liver-resident memory T cells of biased specificities for abundant sporozoite antigens drive malaria protection by radiation-attenuated sporozoite vaccination. PLoS Pathog. 21, e1012731 (2025).","journal-title":"PLoS Pathog."},{"key":"2263_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.4049\/jimmunol.165.3.1453","volume":"165","author":"DL Doolan","year":"2000","unstructured":"Doolan, D. L. & Hoffman, S. L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453\u20131462 (2000).","journal-title":"J. Immunol."},{"key":"2263_CR15","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3978::AID-IMMU3978>3.0.CO;2-0","volume":"29","author":"M Guebre-Xabier","year":"1999","unstructured":"Guebre-Xabier, M., Schwenk, R. & Krzych, U. Memory phenotype CD8+ T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur. J. Immunol. 29, 3978\u20133986 (1999).","journal-title":"Eur. J. Immunol."},{"key":"2263_CR16","doi-asserted-by":"publisher","first-page":"e1000998","DOI":"10.1371\/journal.ppat.1000998","volume":"6","author":"NW Schmidt","year":"2010","unstructured":"Schmidt, N. W., Butler, N. S., Badovinac, V. P. & Harty, J. T. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog. 6, e1000998 (2010).","journal-title":"PLoS Pathog."},{"key":"2263_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1473-3099(19)30300-7","volume":"19","author":"H Tinto","year":"2019","unstructured":"Tinto, H. et al. Long-term incidence of severe malaria following RTS,S\/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. Lancet Infect. Dis. 19, 821\u2013832 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"2263_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","volume":"17","author":"MS Sissoko","year":"2017","unstructured":"Sissoko, M. S. et al. Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect. Dis. 17, 498\u2013509 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"2263_CR19","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/s44321-024-00131-0","volume":"16","author":"D Moita","year":"2024","unstructured":"Moita, D. & Prud\u00eancio, M. Whole-sporozoite malaria vaccines: where we are, where we are going. EMBO Mol. Med. 16, 2279\u20132289 (2024).","journal-title":"EMBO Mol. Med."},{"key":"2263_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein, J. E. et al. Protection against Plasmodium falciparum malaria by PfSPZ vaccine. JCI Insight 2, e89154 (2017).","journal-title":"JCI Insight"},{"key":"2263_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41577-023-00941-2","volume":"24","author":"MMAR van Dorst","year":"2024","unstructured":"van Dorst, M. M. A. R. et al. Immunological factors linked to geographical variation in vaccine responses. Nat. Rev. Immunol. 24, 250\u2013263 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2263_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mib.2016.04.006","volume":"32","author":"CA Long","year":"2016","unstructured":"Long, C. A. & Zavala, F. Malaria vaccines and human immune responses. Curr. Opin. Microbiol. 32, 96\u2013102 (2016).","journal-title":"Curr. Opin. Microbiol."},{"key":"2263_CR23","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41590-023-01562-6","volume":"24","author":"M Ganley","year":"2023","unstructured":"Ganley, M. et al. mRNA vaccine against malaria tailored for liver-resident memory T cells. Nat. Immunol. 24, 1487\u20131498 (2023).","journal-title":"Nat. Immunol."},{"key":"2263_CR24","doi-asserted-by":"publisher","unstructured":"Meibalan, E. & Marti, M. Biology of malaria transmission. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a025452 (2017).","DOI":"10.1101\/cshperspect.a025452"},{"key":"2263_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.2180","volume":"13","author":"NS Butler","year":"2012","unstructured":"Butler, N. S. et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 13, 188\u2013195 (2012).","journal-title":"Nat. Immunol."},{"key":"2263_CR26","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/IAI.01940-14","volume":"82","author":"JW Lin","year":"2014","unstructured":"Lin, J. W. et al. The subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses. Infect. Immun. 82, 4654\u20134665 (2014).","journal-title":"Infect. Immun."},{"key":"2263_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1440-1711.2000.00889.x","volume":"78","author":"SR Clarke","year":"2000","unstructured":"Clarke, S. R. et al. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol. Cell Biol. 78, 110\u2013117 (2000).","journal-title":"Immunol. Cell Biol."},{"key":"2263_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00436-009-1435-8","volume":"105","author":"A Shibui","year":"2009","unstructured":"Shibui, A. et al. CD4+ T cell response in early erythrocytic stage malaria: Plasmodium berghei infection in BALB\/c and C57BL\/6 mice. Parasitol. Res. 105, 281\u2013286 (2009).","journal-title":"Parasitol. Res."},{"key":"2263_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-135","volume":"9","author":"A Afonso","year":"2010","unstructured":"Afonso, A. et al. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene. Malar. J. 9, 135 (2010).","journal-title":"Malar. J."},{"key":"2263_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40588-021-00166-8","volume":"8","author":"T Dalapati","year":"2021","unstructured":"Dalapati, T. & Moore, J. M. Hemozoin: a complex molecule with complex activities. Curr. Clin. Microbiol. Rep. 8, 87\u2013102 (2021).","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"2263_CR31","volume":"2012","author":"R Frita","year":"2012","unstructured":"Frita, R., Carapau, D., Mota, M. M. & H\u00e4nscheid, T. In vivo hemozoin kinetics after clearance of Plasmodium berghei infection in mice. Malar. Res. Treat. 2012, 373086 (2012).","journal-title":"Malar. Res. Treat."},{"key":"2263_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2307\/3285800","volume":"85","author":"MA Levesque","year":"1999","unstructured":"Levesque, M. A., Sullivan, A. D. & Meshnick, S. R. Splenic and hepatic hemozoin in mice after malaria parasite clearance. J. Parasitol. 85, 570\u2013573 (1999).","journal-title":"J. Parasitol."},{"key":"2263_CR33","doi-asserted-by":"publisher","first-page":"e1000559","DOI":"10.1371\/journal.ppat.1000559","volume":"5","author":"MT Shio","year":"2009","unstructured":"Shio, M. T. et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 5, e1000559 (2009).","journal-title":"PLoS Pathog."},{"key":"2263_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109586","volume":"36","author":"AD Pack","year":"2021","unstructured":"Pack, A. D. et al. Hemozoin-mediated inflammasome activation limits long-lived anti-malarial immunity. Cell Rep. 36, 109586 (2021).","journal-title":"Cell Rep."},{"key":"2263_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1084\/jem.20041836","volume":"201","author":"C Coban","year":"2005","unstructured":"Coban, C. et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201, 19\u201325 (2005).","journal-title":"J. Exp. Med."},{"key":"2263_CR36","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.4049\/jimmunol.0903824","volume":"184","author":"X Wu","year":"2010","unstructured":"Wu, X., Gowda, N. M., Kumar, S. & Gowda, D. C. Protein\u2013DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J. Immunol. 184, 4338\u20134348 (2010).","journal-title":"J. Immunol."},{"key":"2263_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.chom.2009.12.003","volume":"7","author":"C Coban","year":"2010","unstructured":"Coban, C. et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 7, 50\u201361 (2010).","journal-title":"Cell Host Microbe"},{"key":"2263_CR38","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/sj.gt.3301248","volume":"7","author":"M Colin","year":"2000","unstructured":"Colin, M. et al. Haemoglobin interferes with the ex vivo luciferase luminescence assay: consequence for detection of luciferase reporter gene expression in vivo. Gene Ther. 7, 1333\u20131336 (2000).","journal-title":"Gene Ther."},{"key":"2263_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro, J. R. & Farber, D. L. COVID-19 vaccines: modes of immune activation and future challenges. Nat. Rev. Immunol. 21, 195\u2013197 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2263_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 592, 616\u2013622 (2021).","journal-title":"Nature"},{"key":"2263_CR41","doi-asserted-by":"publisher","unstructured":"Hassert, M. et al. Regenerating murine CD8+ lung tissue resident memory T cells after targeted radiation exposure. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20231144 (2024).","DOI":"10.1084\/jem.20231144"},{"key":"2263_CR42","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.4049\/jimmunol.1800740","volume":"201","author":"TM Olsen","year":"2018","unstructured":"Olsen, T. M., Stone, B. C., Chuenchob, V. & Murphy, S. C. Prime-and-trap malaria vaccination to generate protective CD8+ liver-resident memory T cells. J. Immunol. 201, 1984\u20131993 (2018).","journal-title":"J. Immunol."},{"key":"2263_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41541-023-00799-4","volume":"9","author":"Z MacMillen","year":"2024","unstructured":"MacMillen, Z. et al. Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. npj Vaccines 9, 12 (2024).","journal-title":"npj Vaccines"},{"key":"2263_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chom.2019.02.014","volume":"25","author":"SP Kurup","year":"2019","unstructured":"Kurup, S. P. et al. Monocyte-derived CD11c+ cells acquire Plasmodium from hepatocytes to prime CD8 T cell immunity to liver-stage malaria. Cell Host Microbe 25, 565\u2013577.e566 (2019).","journal-title":"Cell Host Microbe"},{"key":"2263_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/infdis\/jis366","volume":"206","author":"T Woodberry","year":"2012","unstructured":"Woodberry, T. et al. Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J. Infect. Dis. 206, 333\u2013340 (2012).","journal-title":"J. Infect. Dis."},{"key":"2263_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0925-4439(93)90089-J","volume":"1181","author":"E Schwarzer","year":"1993","unstructured":"Schwarzer, E., Turrini, F., Giribaldi, G., Cappadoro, M. & Arese, P. Phagocytosis of P. falciparum malarial pigment hemozoin by human monocytes inactivates monocyte protein kinase C. Biochim. Biophys. Acta 1181, 51\u201354 (1993).","journal-title":"Biochim. Biophys. Acta"},{"key":"2263_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1473-3099(21)00332-7","volume":"22","author":"MS Sissoko","year":"2022","unstructured":"Sissoko, M. S. et al. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Lancet Infect. Dis. 22, 377\u2013389 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"2263_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/biof.1119","volume":"40","author":"A Tyberghein","year":"2014","unstructured":"Tyberghein, A., Deroost, K., Schwarzer, E., Arese, P. & Van den Steen, P. E. Immunopathological effects of malaria pigment or hemozoin and other crystals. Biofactors 40, 59\u201378 (2014).","journal-title":"Biofactors"},{"key":"2263_CR49","first-page":"143","volume":"50","author":"E Schwarzer","year":"2008","unstructured":"Schwarzer, E., Skorokhod, O. A., Barrera, V. & Arese, P. Hemozoin and the human monocyte\u2014a brief review of their interactions. Parassitologia 50, 143\u2013145 (2008).","journal-title":"Parassitologia"},{"key":"2263_CR50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.pt.2013.07.005","volume":"29","author":"M Boura","year":"2013","unstructured":"Boura, M., Frita, R., G\u00f3is, A., Carvalho, T. & H\u00e4nscheid, T. The hemozoin conundrum: is malaria pigment immune-activating, inhibiting, or simply a bystander?. Trends Parasitol. 29, 469\u2013476 (2013).","journal-title":"Trends Parasitol."},{"key":"2263_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/jbiol34","volume":"5","author":"OR Millington","year":"2006","unstructured":"Millington, O. R., Di Lorenzo, C., Phillips, R. S., Garside, P. & Brewer, J. M. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 5, 5 (2006).","journal-title":"J. Biol."},{"key":"2263_CR52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pt.2020.09.016","volume":"37","author":"T-T Pham","year":"2021","unstructured":"Pham, T.-T., Lamb, T. J., Deroost, K., Opdenakker, G. & Van den Steen, P. E. Hemozoin in malarial complications: more questions than answers. Trends Parasitol. 37, 226\u2013239 (2021).","journal-title":"Trends Parasitol."},{"key":"2263_CR53","doi-asserted-by":"publisher","unstructured":"Harding, C. L., Villarino, N. F., Valente, E., Schwarzer, E. & Schmidt, N. W. Plasmodium impairs antibacterial innate immunity to systemic infections in part through hemozoin-bound bioactive molecules. Front. Cell. Infect. Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.00328 (2020).","DOI":"10.3389\/fcimb.2020.00328"},{"key":"2263_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ni1300","volume":"7","author":"NS Wilson","year":"2006","unstructured":"Wilson, N. S. et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7, 165\u2013172 (2006).","journal-title":"Nat. Immunol."},{"key":"2263_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20021072","volume":"197","author":"C Ocan\u0303a-Morgner","year":"2003","unstructured":"Ocan\u0303a-Morgner, C., Mota, M. M. & Rodriguez, A. Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 197, 143\u2013151 (2003).","journal-title":"J. Exp. Med."},{"key":"2263_CR56","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1182\/blood-2002-03-0979","volume":"101","author":"E Schwarzer","year":"2003","unstructured":"Schwarzer, E., Kuhn, H., Valente, E. & Arese, P. Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions. Blood 101, 722\u2013728 (2003).","journal-title":"Blood"},{"key":"2263_CR57","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1182\/blood-2006-05-018697","volume":"108","author":"C Casals-Pascual","year":"2006","unstructured":"Casals-Pascual, C. et al. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 108, 2569\u20132577 (2006).","journal-title":"Blood"},{"key":"2263_CR58","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1073\/pnas.0608745104","volume":"104","author":"P Parroche","year":"2007","unstructured":"Parroche, P. et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl Acad. Sci. USA 104, 1919\u20131924 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2263_CR59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.celrep.2013.12.014","volume":"6","author":"P Kalantari","year":"2014","unstructured":"Kalantari, P. et al. Dual engagement of the NLRP3 and AIM2 inflammasomes by Plasmodium-derived hemozoin and DNA during malaria. Cell Rep. 6, 196\u2013210 (2014).","journal-title":"Cell Rep."},{"key":"2263_CR60","doi-asserted-by":"publisher","unstructured":"Franco, A. et al. Hemozoin-induced IFN-\u03b3 production mediates innate immune protection against sporozoite infection. Microbes Infect. https:\/\/doi.org\/10.1016\/j.micinf.2024.105343 (2024).","DOI":"10.1016\/j.micinf.2024.105343"},{"key":"2263_CR61","doi-asserted-by":"publisher","unstructured":"Kularatne, R. N., Crist, R. M. & Stern, S. T. The future of tissue-targeted lipid nanoparticle-mediated nucleic acid delivery. Pharmaceuticals https:\/\/doi.org\/10.3390\/ph15070897 (2022).","DOI":"10.3390\/ph15070897"},{"key":"2263_CR62","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-022-05466-7","volume":"612","author":"AG Eappen","year":"2022","unstructured":"Eappen, A. G. et al. In vitro production of infectious Plasmodium falciparum sporozoites. Nature 612, 534\u2013539 (2022).","journal-title":"Nature"},{"key":"2263_CR63","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1073\/pnas.1504887113","volume":"113","author":"NF Villarino","year":"2016","unstructured":"Villarino, N. F. et al. Composition of the gut microbiota modulates the severity of malaria. Proc. Natl Acad. Sci. USA 113, 2235\u20132240 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2263_CR64","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.4049\/jimmunol.1600155","volume":"196","author":"KL Doll","year":"2016","unstructured":"Doll, K. L., Pewe, L. L., Kurup, S. P. & Harty, J. T. Discriminating protective from nonprotective Plasmodium-specific CD8+ T cell responses. J. Immunol. 196, 4253\u20134262 (2016).","journal-title":"J. Immunol."},{"key":"2263_CR65","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/nm.4395","volume":"23","author":"SP Kurup","year":"2017","unstructured":"Kurup, S. P. et al. Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4. Nat. Med. 23, 1220\u20131225 (2017).","journal-title":"Nat. Med."},{"key":"2263_CR66","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm1257","volume":"11","author":"VP Badovinac","year":"2005","unstructured":"Badovinac, V. P., Messingham, K. A. N., Jabbari, A., Haring, J. S. & Harty, J. T. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11, 748\u2013756 (2005).","journal-title":"Nat. Med."},{"key":"2263_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpddr.2017.02.001","volume":"7","author":"JM Pisciotta","year":"2017","unstructured":"Pisciotta, J. M., Scholl, P. F., Shuman, J. L., Shualev, V. & Sullivan, D. J. Quantitative characterization of hemozoin in Plasmodium berghei and vivax. Int. J. Parasitol. Drugs Drug Resist. 7, 110\u2013119 (2017).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"2263_CR68","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.4049\/jimmunol.158.6.2723","volume":"158","author":"Z Shen","year":"1997","unstructured":"Shen, Z., Reznikoff, G., Dranoff, G. & Rock, K. L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723\u20132730 (1997).","journal-title":"J. Immunol."},{"key":"2263_CR69","doi-asserted-by":"publisher","first-page":"8497","DOI":"10.1128\/jvi.71.11.8497-8503.1997","volume":"71","author":"F Rodriguez","year":"1997","unstructured":"Rodriguez, F., Zhang, J. & Whitton, J. L. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71, 8497\u20138503 (1997).","journal-title":"J. Virol."},{"key":"2263_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc9450","volume":"6","author":"D Rosenblum","year":"2020","unstructured":"Rosenblum, D. et al. CRISPR\u2013Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Sci. Adv. 6, eabc9450 (2020).","journal-title":"Sci. Adv."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02263-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02263-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02263-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:02:09Z","timestamp":1772712129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02263-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1038\/s41564-026-02263-0","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}